ABSTRACT
Bardet-Biedl syndrome (BBS) is a genetically heterogeneous autosomal recessive disorder with the primary clinical features of obesity, pigmented retinopathy, polydactyly, hypogenitalism, mental retardation and renal anomalies. Associated features of the disorder include diabetes mellitus, hypertension and congenital heart disease. There are six known BBS loci, mapping to chromosomes 2, 3, 11, 15, 16 and 20. The BBS2 locus was initially mapped to an 18 cM interval on chromosome 16q21 with a large inbred Bedouin kindred. Further analysis of the Bedouin population allowed for the fine mapping of this locus to a 2 cM region distal to marker D16S408. Physical mapping and sequence analysis of this region resulted in the identification of a number of known genes and expressed sequence tag clusters. Mutation screening of a novel gene (BBS2) with a wide pattern of tissue expression revealed homozygous mutations in two inbred pedigrees, including the large Bedouin kindred used to initially identify the BBS2 locus. In addition, mutations were found in three of 18 unrelated BBS probands from small nuclear families.
Subject(s)
Bardet-Biedl Syndrome/genetics , Chromosomes, Human, Pair 16 , Conserved Sequence , Amino Acid Sequence , Animals , Chromosome Mapping , Cloning, Molecular , Evolution, Molecular , Female , Genetic Testing , Humans , Male , Mice , Molecular Sequence Data , Mutation , Pedigree , Proteins/genetics , RatsABSTRACT
The dark-adapted electroretinogram (ERG) of patients with Duchenne and Becker muscular dystrophy (DMD/BMD) shows a marked reduction in b-wave amplitude. Genotype-phenotype studies of mouse models for DMD show position-specific effects of the mutations upon the phenotype: mice with 5' defects of dystrophin have normal ERGs, those with defects in the central region have a normal b-wave amplitude associated with prolonged implicit times for both the b-wave and oscillatory potentials, and mice with 3' defects have a phenotype similar to that seen in DMD/BMD patients. The mouse studies suggest a key role for the carboxyl terminal dystrophin isoform, Dp260, in retinal electrophysiology. We have undertaken a systematic evaluation of DMD/BMD patients through clinical examination and review of the literature in order to determine whether the position-specific effects of mutations noted in the mouse are present in man. We have found that, in man, a wider variation of DMD defects correlate with reductions in the b-wave amplitude. Individuals with normal ERGs have mutations predominantly located 5' of the transcript initiation site of Dp260. Our results suggest that the most important determinant in the ERG b-wave phenotype is the mutation position, rather than muscle disease severity. Forty-six per cent of patients with mutations 5' of the Dp260 transcript start site have abnormal ERGs, as opposed to 94% with more distal mutations. The human genotype-phenotype correlations are consistent with a role for Dp260 in normal retinal electrophysiology and may also reflect the expression of other C-terminal dystrophin isoforms and their contributions to retinal signal transmission.
Subject(s)
Dystrophin/genetics , Electroretinography , Muscular Dystrophies/genetics , Mutation , Exons , Gene Deletion , Genotype , Humans , Models, Genetic , Muscular Dystrophies/physiopathology , Phenotype , Polymerase Chain Reaction , Promoter Regions, Genetic , RNA, Messenger/analysisABSTRACT
Both pigmentation and otic defects of Waardenburg Syndrome and Hirschsprung's disease have a common origin in neural crest cells and were described in 1951 and 1887, respectively. The clinical manifestations of both in the same patient were described in 1981 in 12 infants so afflicted. The authors present such a case of long segment aganglionosis in a 15-day-old Marshallese girl with Waardenburg-Shah syndrome and discuss diagnosis, treatment, and prognosis.
Subject(s)
Hirschsprung Disease/complications , Waardenburg Syndrome/complications , Fatal Outcome , Female , Humans , Infant, NewbornABSTRACT
A male child with metabolic acidosis was diagnosed as having dihydrolipoamide dehydrogenase (E3) deficiency. E3 activity of the proband's cultured fibroblasts and blood lymphocytes was 3-9% of normal, while in the parent's lymphocytes it was about 60% of normal. The proband's pyruvate dehydrogenase complex (PDC) and the alpha-ketoglutarate dehydrogenase complex activities from cultured skin fibroblasts were 12% and 6% of normal, respectively. PDC activity in the parents cultured fibroblasts was 25-31% of normal. Western and Northern blot analyses showed similar quantities of E3 protein and mRNA in cultured fibroblasts from the proband and his parents. DNA sequencing of cloned full-length E3 cDNAs, from the proband and the parents, showed two mutations on different alleles of proband were inherited from the parents. One mutation is a three nucleotide (AGG) deletion, from the mother, resulting in deletion of Gly101 in the FAD binding domain. The other mutation is a nucleotide substitution (G to A), from the father, leading to substitution of Lys for Glu340 in the central domain. The same deletion mutation was found in E3 cDNA from a chorionic villus sample and cultured fibroblasts obtained from the mother's subsequent offspring. This finding illustrates the possibility of successful prenatal diagnosis of E3 deficiency utilizing mutations characterized prior to initiation of pregnancy.
Subject(s)
Amino Acid Metabolism, Inborn Errors/genetics , Dihydrolipoamide Dehydrogenase/deficiency , Acidosis/enzymology , Acidosis/genetics , DNA, Complementary/genetics , Dihydrolipoamide Dehydrogenase/genetics , Female , Humans , Infant, Newborn , Ketoglutarate Dehydrogenase Complex/metabolism , Liver/enzymology , Male , Muscle, Skeletal/enzymology , Myocardium/enzymology , Pedigree , Point Mutation , Pyruvate Dehydrogenase Complex/metabolism , Sequence DeletionSubject(s)
Dissociative Disorders/psychology , Psychiatry , Stress Disorders, Post-Traumatic/psychology , Suggestion , Amnesia/psychology , Child , Child Abuse/psychology , Crime/psychology , Dissociative Disorders/diagnosis , Dissociative Disorders/therapy , Ethics, Medical , Humans , Psychology, Child , Stress Disorders, Post-Traumatic/therapy , Torture/psychologySubject(s)
Amino Acid Metabolism, Inborn Errors/diagnosis , Anticonvulsants/therapeutic use , Brain Diseases, Metabolic/diagnosis , Leucovorin/therapeutic use , Seizures/complications , Amino Acid Metabolism, Inborn Errors/cerebrospinal fluid , Amino Acid Metabolism, Inborn Errors/complications , Anticonvulsants/administration & dosage , Brain Diseases, Metabolic/cerebrospinal fluid , Brain Diseases, Metabolic/complications , Chromatography, High Pressure Liquid , Fatal Outcome , Female , Humans , Infant, Newborn , Leucovorin/administration & dosage , Male , Neurotransmitter Agents/analysisABSTRACT
PURPOSE: Dystrophin, the Duchenne muscular dystrophy gene product, has been localized to the outer plexiform layer of normal human retina. The purpose of this study is to define completely the ocular phenotype associated with mutations at Xp21, the Duchenne muscular dystrophy gene locus. METHODS: Twenty-one patients with a diagnosis of Duchenne muscular dystrophy and five patients with Becker muscular dystrophy had ophthalmologic examinations, including electroretinograms (ERGs). Electroretinogram results were correlated with respect to patient DNA analysis. RESULTS: Twenty-three (88%) patients had reduced scotopic b-wave amplitudes to bright-white flash stimulus, including nine with negative-shaped ERGs. Rod-isolated responses were reduced or not recordable above noise in 14 (67%) patients. Most isolated cone responses (92%) were normal. Flicker amplitudes were reduced in seven patients. Two of these patients with proximal (5' end) deletions had normal scotopic b-waves to dim blue and bright-white flash stimulus. Patients with deletions toward the middle of the gene had greater reductions in their scotopic b-wave amplitudes than patients with deletions located toward the 5' end. Most patients had normal color vision, extraocular muscle function, and Snellen visual acuity. Increased macular pigmentation was seen in 16 patients with Duchenne muscular dystrophy. CONCLUSION: Most patients with Duchenne or Becker muscular dystrophy have evidence of abnormal scotopic ERGs. Patients with deletions in the central region of the gene had the most severe ERG changes. This study supports previous suggestions that dystrophin may play a role in retinal neurotransmission. The presence of increased macular pigmentation and normal photopic ERGs distinguishes patients with Duchenne muscular dystrophy mutations from other X-linked retinal disorders with negative-shaped ERGs.
Subject(s)
Muscular Dystrophies/physiopathology , Retina/physiopathology , Adolescent , Adult , Child , Color Perception , DNA/analysis , Depth Perception , Electroretinography , Female , Fundus Oculi , Humans , Light , Male , Middle Aged , Muscular Dystrophies/genetics , Phenotype , Refractive Errors/physiopathology , Vision, Binocular , Visual AcuityABSTRACT
A 45-month-old girl with 5-oxoprolinuria (pyroglutamic aciduria), hemolysis, and marked glutathione depletion caused by deficiency of glutathione synthetase was followed before and during treatment with ascorbate or N-acetylcysteine. High doses of ascorbate (0.7 mmol/kg per day) or N-acetylcysteine (6 mmol/kg per day) were given for 1 to 2 weeks without any obvious deleterious side effects. Ascorbate markedly increased lymphocyte (4-fold) and plasma (8-fold) levels of glutathione. N-Acetylcysteine also increased lymphocyte (3.5-fold) and plasma (6-fold) levels of glutathione. After these treatments were discontinued, lymphocyte and plasma glutathione levels decreased rapidly to pretreatment levels. Ascorbate treatment was extended for 1 year, and lymphocyte (4-fold) and plasma (2- to 5-fold) glutathione levels remained elevated above baseline. In parallel, the hematocrit increased from 25.4% to 32.6%, and the reticulocyte count decreased from 11% to 4%. The results demonstrate that ascorbate and N-acetylcysteine can decrease erythrocyte turnover in patients with hereditary glutathione deficiency by increasing glutathione levels.
Subject(s)
Acetylcysteine/therapeutic use , Ascorbic Acid/therapeutic use , Glutathione Synthase/deficiency , Child, Preschool , Female , Glutathione Synthase/analysis , Glutathione Synthase/blood , Humans , Lymphocytes/enzymology , Metabolism, Inborn Errors/blood , Metabolism, Inborn Errors/drug therapy , Vitamin E/therapeutic useABSTRACT
OBJECTIVE: To determine whether abnormal configurations on electroretinogram were a consistent finding in patients with Xp21 deletion and to characterize the associated ophthalmologic phenotype. DESIGN: Case series. SETTING: University hospitals and eye institutes. PATIENTS: Five patients with complex glycerol kinase deficiency (Duchenne-type or Becker's muscular dystrophy, glycerol kinase deficiency, and congenital adrenal hypoplasia) and demonstrated chromosomal deletions at Xp21. Control patients were matched by age. MAIN OUTCOME MEASURES: Clinical information was obtained from medical records. Complete ophthalmologic examinations were performed. Electroretinography was performed using a Ganzfeld technique and chloral hydrate sedation. RESULTS: We report the clinical features and abnormal configurations on electroretinograms of five patients with complex glycerol kinase deficiency, including follow-up studies on a previously described patient. The original patient had ocular hypopigmentation; four, strabismus; two, myopia; three, astigmatism; and one, symptomatic night blindness. All had negative configurations on scotopic electroretinograms showing a reduced-amplitude B wave in the dark-adapted state. CONCLUSIONS: Our original report suggested a diagnosis of Aland Island eye disease, which appears to be an incomplete form of congenital stationary night blindness. Linkage data place Aland Island eye disease and congenital stationary night blindness at Xp11, whereas our patients had deletions at Xp21. The phenotype reported here may represent the effects of a single gene defect or the compound effects of the Xp21 contiguous gene syndrome (complex glycerol kinase deficiency). The phenotype is referred to as Oregon eye disease.
Subject(s)
Albinism, Ocular/genetics , Chromosome Aberrations/genetics , Chromosome Deletion , Glycerol Kinase/genetics , Muscular Dystrophies/genetics , X Chromosome , Adolescent , Albinism, Ocular/physiopathology , Child , Child, Preschool , Chromosome Aberrations/physiopathology , Chromosome Disorders , Electroretinography , Glycerol Kinase/deficiency , Humans , Male , Muscular Dystrophies/enzymology , Muscular Dystrophies/physiopathology , Phenotype , Retina/physiology , SyndromeABSTRACT
We report 27 children, aged 14 months to 9 years, who had megalencephaly, hypotonia, proximal muscle weakness, speech and motor delay, and increased intracellular lipid (myoliposis) in needle muscle biopsy specimens. The patients had many features of the Ruvalcaba-Myhre-Smith syndrome, and in 17 families we confirmed the autosomal dominant inheritance pattern previously suggested. Muscle carnitine content was low in all 11 patients and all 4 affected relatives tested. All 27 probands were treated with oral L-carnitine; a clinical response was noted in 17. We speculate that myoliposis may be found in other disorders with megalencephaly and muscle symptoms. In such cases, muscle carnitine deficiency should be considered. The reason for the reduced muscle carnitine content is not known.
Subject(s)
Abnormalities, Multiple/diagnosis , Brain/abnormalities , Carnitine/deficiency , Gigantism/diagnosis , Muscular Diseases/diagnosis , Abnormalities, Multiple/drug therapy , Abnormalities, Multiple/metabolism , Abnormalities, Multiple/pathology , Administration, Oral , Biopsy, Needle , Carnitine/administration & dosage , Carnitine/metabolism , Child , Child, Preschool , Female , Gigantism/drug therapy , Gigantism/metabolism , Gigantism/pathology , Histocytochemistry , Humans , Infant , Lipid Metabolism , Male , Muscles/metabolism , Muscles/pathology , Muscular Diseases/drug therapy , Muscular Diseases/metabolism , Muscular Diseases/pathology , SyndromeABSTRACT
We have studied retinal function by electroretinography in five Becker and six Duchenne muscular dystrophy patients. All had abnormal electroretinograms with a markedly reduced amplitude for the b-wave in the dark-adapted state. Using three antisera raised to different domains of dystrophin, we identified dystrophin in the outer plexiform layer of human retina. The retinal dystrophin is present in multiple isoforms as the result of alternative splicing. The localization of dystrophin to the outer plexiform layer coincident with the abnormal b-wave suggests that dystrophin is required for normal retinal electrophysiology.
Subject(s)
Dystrophin/physiology , Electroretinography , Eye Proteins/physiology , Muscular Dystrophies/physiopathology , Retina/chemistry , Adolescent , Adult , Base Sequence , Child , Dystrophin/biosynthesis , Dystrophin/genetics , Eye Proteins/biosynthesis , Eye Proteins/genetics , Humans , Molecular Sequence Data , Muscular Dystrophies/genetics , Organ Specificity , Polymerase Chain Reaction , RNA, Messenger/analysis , Retina/physiopathologySubject(s)
Decalcification, Pathologic/etiology , Genetic Diseases, Inborn , Hypercalcemia/complications , Hyperparathyroidism, Secondary/etiology , Calcium/urine , Decalcification, Pathologic/diagnostic imaging , Female , Genetic Diseases, Inborn/blood , Genetic Diseases, Inborn/urine , Humans , Hypercalcemia/blood , Hypercalcemia/urine , Hyperparathyroidism, Secondary/blood , Infant, Newborn , RadiographyABSTRACT
HYPERKALAEMIC periodic paralysis (HYPP) is an autosomal dominant disease that results in episodic electrical inexcitability and paralysis of skeletal muscle. Electrophysiological data indicate that tetrodotoxin-sensitive sodium channels from muscle cells of HYPP-affected individuals show abnormal inactivation. Genetic analysis of nine HYPP families has shown tight linkage between the adult skeletal muscle sodium channel alpha-subunit gene on chromosome 17q and the disease (lod score, z = 24; recombination frequency 0 = 0), strongly suggesting that mutations of the alpha-subunit gene cause HYPP. We sequenced the alpha-subunit coding region isolated from muscle biopsies from affected (familial HYPP) and control individuals by cross-species polymerase chain reaction-mediated complementary DNA cloning. We have identified an A----G substitution in the patient's messenger RNA that causes a Met----Val change in a highly conserved region of the alpha-subunit, predicted to be in a transmembrane domain. This same change was found in a sporadic case of HYPP as a new mutation. We have therefore discovered a voltage-gated channel mutation responsible for a human genetic disease.
Subject(s)
Muscles/physiology , Paralyses, Familial Periodic/genetics , Sodium Channels/genetics , Amino Acid Sequence , Animals , Chromosomes, Human, Pair 17 , DNA Mutational Analysis , Drosophila , Eels , Genes, Dominant , Humans , Membrane Proteins/genetics , Molecular Sequence Data , Pedigree , Potassium/physiology , Rats , Sequence AlignmentABSTRACT
Seven boys with an apparently X-linked syndrome of dilated cardiomyopathy, growth retardation, neutropenia, and persistently elevated urinary levels of 3-methylglutaconate, 3-methylglutarate, and 2-ethylhydracrylate were studied. The natural history of the disorder was characterized by severe or lethal cardiac disease and recurrent infections during infancy and early childhood but relative improvement in later childhood. The initial presentation of the syndrome varied from congenital dilated cardiomyopathy to infantile congestive heart failure to isolated neutropenia without clinical evidence of heart disease. The excretion of 3-methylglutaconate and 3-methylglutarate appeared to be independent of the metabolism of leucine, the presumed precursor of these organic acids in humans. Although the cause of the organic aciduria remains obscure, the constellation of biochemical and clinical abnormalities forms a distinct syndrome that may be a relatively common cause of dilated cardiomyopathy or neutropenia in boys during infancy and childhood.
Subject(s)
Cardiomyopathy, Dilated/genetics , Glutarates/urine , Growth Disorders/genetics , Neutropenia/genetics , X Chromosome , Adult , Cardiomyopathy, Dilated/metabolism , Cardiomyopathy, Dilated/pathology , Child , Child, Preschool , Chromatography, High Pressure Liquid , Fumarates/urine , Growth Disorders/metabolism , Heart Failure/genetics , Humans , Male , Meglutol/analogs & derivatives , Meglutol/urine , Muscular Diseases/genetics , Muscular Diseases/pathology , Neutropenia/metabolism , Neutropenia/pathology , Pedigree , SyndromeABSTRACT
We have reviewed the structure, function, and biogenesis of mammalian cytochrome c oxidase, examined the tissue-specific expression of isoforms of cytochrome c oxidase subunits in different mammals, and attempted to correlate the data with our knowledge of cytochrome c oxidase deficiency, illustrated by one particular patient. Cytochrome c oxidase was isolated from bovine tissues, and individual subunits examined by SDS-PAGE, N-terminal peptide sequencing, and antibody binding. Isoforms of subunits VIa, VIIa, and VIII were identified, manifesting one pattern of expression in heart and skeletal muscle, and another in liver, kidney, and brain. In rat heart and liver, only one form of subunit VIIa was identified. Northern analysis of bovine and rat tissues suggested that the tissue-specific expression of subunits VIa and VIII is regulated transcriptionally in liver, kidney, and brain, and posttranscriptionally in heart and skeletal muscle. In humans, antibody binding documented isoforms of subunits VIa and VIIa, with the pattern of expression in heart and skeletal muscle differing from that in liver, kidney, and brain; our data suggested that both isoforms of subunit VIa may be expressed in human heart. In a patient with cytochrome c oxidase deficiency, the clinical, morphologic, and biochemical manifestations were much more severe in heart than in skeletal muscle. Antibody binding suggested partial assembly of the enzyme in heart. These and other data suggest considerably more variability in the tissue-specific expression of isoforms of cytochrome c oxidase subunits than previously recognized.
Subject(s)
Cytochrome-c Oxidase Deficiency , Amino Acid Sequence , Animals , Cardiomyopathies/enzymology , Cardiomyopathies/etiology , Cattle , Electron Transport Complex IV/chemistry , Electron Transport Complex IV/genetics , Female , Humans , Infant, Newborn , Molecular Sequence Data , Oxygen Consumption , Rats , Species Specificity , Tissue DistributionABSTRACT
Aland Island Eye Disease (AIED) is an X-linked form of ocular hypopigmentation--also known as Forsius-Eriksson, or type 2, ocular albinism--in which affected males demonstrate subnormal visual acuity, protanomalous red-green colorblindness, axial myopia, astigmatism, hypoplasia of the fovea, and hypopigmentation of the fundus. A patient has previously been described who, in addition to AIED, manifested a contiguous gene syndrome which included congenital adrenal hypoplasia (AHC), glycerol kinase deficiency (GKD), and Duchenne muscular dystrophy (DMD). In the present paper report we report the molecular genetic analysis of his deletion. Initially, multiplex polymerase-chain-reaction amplification was used to screen for a DMD-locus deletion which was then further characterized, using DMD cDNA and genomic probes, via Southern blot analysis. The deletion includes the region encompassed by probes C7 (DXS28) and DMD cDNA 8. Probes B24 (DXS67) and DMD cDNA 5b-7 show normal hybridization patterns and appear to flank the deletion, while the DMD cDNA 8 detects a junction fragment. Molecular genetic techniques have mapped the deletion in this patient to the subbands Xp21.3-21.2, between DXS67 and DMD.
Subject(s)
Albinism, Ocular/genetics , Chromosome Deletion , Chromosomes, Human, Pair 21 , Muscular Dystrophies/genetics , Albinism, Ocular/complications , Chromosome Mapping , DNA Probes , Humans , Muscular Dystrophies/complications , Mutation , Polymerase Chain ReactionABSTRACT
Rhizomelic chondrodysplasia punctata (RCDP), a peroxisomal disorder, is considered to be a lethal neonatal autosomal recessive chondrodysplasia. We report five patients, three of whom survived beyond 1 year, and we summarize the findings in 21 patients from a literature review who survived beyond 1 year. In those patients that survive, there is a high association of spasticity, psychomotor retardation, growth failure, seizures, thermoregulatory instability, feeding difficulty, and recurrent otitis media and pneumonia. Three of our five patients had no radiographic evidence of vertebral body clefts, a finding which has previously been considered invariable in RCDP. Three of our patients had distinctive facies that differ from the classic Conradi-Hunermann facies.
Subject(s)
Chondrodysplasia Punctata/genetics , Chromosome Aberrations/genetics , Genes, Recessive , Bone and Bones/diagnostic imaging , Child , Child, Preschool , Chondrodysplasia Punctata/diagnostic imaging , Chromosome Disorders , Epiphyses/diagnostic imaging , Female , Follow-Up Studies , Humans , Infant , Male , RadiographyABSTRACT
Glycerol kinase deficiency (GKD) has been described in isolation and in complex phenotypes including either congenital adrenal hypoplasia, Duchenne muscular dystrophy, or both. Cytogenetic and molecular studies have localized these defects to a deletion involving the X chromosome at band Xp21, consistent with its X-linked recessive pattern of inheritance. Other clinical findings in the complex glycerol kinase deficiency (CGKD) patients are mental retardation, short stature, and hypogonadotropic hypogonadism. We report on a 6-year-old boy who, in addition to the CGKD phenotype described above, had ocular hypopigmentation consistent with Forsius-Eriksson ocular albinism, also known as type 2 ocular albinism or Aland Island eye disease. Cytogenetic analysis shows an interstitial deletion in the short arm of the X-chromosome at Xp21.
Subject(s)
Adrenal Insufficiency/congenital , Albinism/genetics , Chromosome Deletion , Glycerol Kinase/deficiency , Muscular Dystrophies/genetics , Phosphotransferases/deficiency , X Chromosome , Adrenal Insufficiency/genetics , Child , Chromosome Banding , Humans , Intellectual Disability/genetics , Male , SyndromeABSTRACT
Familial hypocalciuric hypercalcemia (FHH) is a benign autosomal dominant disorder. Infants affected with FHH however, born to unaffected mothers may develop life-threatening autonomous hyperparathyroidism, the mechanism of which is not clearly understood. There is little information recorded in the literature regarding the opposite scenario, i.e., unaffected infants born to affected mothers. Because fetal parathyroid suppression presumably occurs secondary to high maternal calciums, neonatal hypocalcemia would be expected. The authors present a case of an infant with the latter circumstances who presents with late onset, life-threatening hypocalcemia secondary to relative hypoparathyroidism. The authors explored the possibility that vitamin D deficiency and/or acute environmental stress facilitated the decompensation. The patient required therapy for 2 months.
Subject(s)
Hypercalcemia/complications , Hypocalcemia/etiology , Infant, Newborn, Diseases/etiology , Calcium/urine , Female , Humans , Hypercalcemia/genetics , Hypoparathyroidism/complications , Infant, Newborn , Male , Time FactorsABSTRACT
We describe a young girl who presented with recurrent episodes of central nervous system (CNS) demyelination mimicking multiple sclerosis. Metabolic evaluations and decreased oxidation of [9,10(n)-3H] palmitate demonstrated defective mitochondrial beta oxidation, but complementation studies of the patient's cells, fused with cell lines with known defects of beta oxidation, failed to identify a known disorder. While progressive CNS demyelination has occurred in patients with defective peroxisomal very long-chain fatty acid oxidation, this is the 1st time it has occurred with defective mitochondrial beta oxidation. This patient appears to represent a novel disorder of beta oxidation producing intermittent demyelination with profound CNS symptoms. Recognition of the defect led to appropriate therapy, which caused marked clinical improvement.